Phospho-TAL1(T90) Antibody Blocking peptide
€363.00
In stock
SKU
AC-BP3690a
Background:
TAL1 is implicated in the genesis of hemopoietic malignancies. It may play an important role in hemopoietic differentiation and serves as a positive regulator of erythroid differentiation.
Other Names:
T-cell acute lymphocytic leukemia protein 1, TAL-1, Class A basic helix-loop-helix protein 17, bHLHa17, Stem cell protein, T-cell leukemia/lymphoma protein 5, TAL1, BHLHA17, SCL, TCL5
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP3690a was selected from the region of human Phospho-TAL1-pT90. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: TAL1
Gene ID: 6886
Primary Accession: P17542
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
TAL1 is implicated in the genesis of hemopoietic malignancies. It may play an important role in hemopoietic differentiation and serves as a positive regulator of erythroid differentiation.
Other Names:
T-cell acute lymphocytic leukemia protein 1, TAL-1, Class A basic helix-loop-helix protein 17, bHLHa17, Stem cell protein, T-cell leukemia/lymphoma protein 5, TAL1, BHLHA17, SCL, TCL5
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP3690a was selected from the region of human Phospho-TAL1-pT90. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: TAL1
Gene ID: 6886
Primary Accession: P17542
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review